A minimally invasive, implantable device designed to deliver pain medicine aims to ensure patient compliance and stymie opiate abuse, according to a report from MedCity News.
The device, approximately the size and shape of a shirt button, can deliver an opiate for 30 to 90 days without any moving parts. The first application of the technology will deliver hydromorphone for treatment of moderate to severe chronic pain in cancer patients.
According to the Axxia Pharmaceuticals, the device developer, it can deliver continuous dosing without an initial burst of the drug upon implantation and without slowing down as the concentration of the drug decreases. The device can also be easily customized with different dosages and release durations, and can be implanted and removed by a nurse or physician’s assistant in less than 10 minutes without sutures.
Related Articles on Pain Management:
5 Ways to Improve Profitability at Pain-Driven ASCs
15 New Statistics on Pain Management Case Volume in ASCs
FDA Panel Allows Painkiller Developers to Continue Drug Trials
The device, approximately the size and shape of a shirt button, can deliver an opiate for 30 to 90 days without any moving parts. The first application of the technology will deliver hydromorphone for treatment of moderate to severe chronic pain in cancer patients.
According to the Axxia Pharmaceuticals, the device developer, it can deliver continuous dosing without an initial burst of the drug upon implantation and without slowing down as the concentration of the drug decreases. The device can also be easily customized with different dosages and release durations, and can be implanted and removed by a nurse or physician’s assistant in less than 10 minutes without sutures.
Related Articles on Pain Management:
5 Ways to Improve Profitability at Pain-Driven ASCs
15 New Statistics on Pain Management Case Volume in ASCs
FDA Panel Allows Painkiller Developers to Continue Drug Trials